Rivaroxaban versus warfarin for the management of left ventricle thrombus.

Monirah A AlbabtainYahya AlhebaishiOla Al-YafiHatim KheirallahAdel OthmanHaneen AlghosoonAmr A ArafatAhmed Alfagih

Published in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2021)

Rivaroxaban was as effective and safe as warfarin in managing patients with left ventricle thrombus. Larger randomized clinical trials are recommended to confirm our findings.

Keyphrases

atrial fibrillation
venous thromboembolism
direct oral anticoagulants
pulmonary artery
pulmonary hypertension
oral anticoagulants
mitral valve
pulmonary embolism
heart failure
congenital heart disease